designing antibody sequences at massive scale, predicting their properties,
validating via experiments, and self-improving iteratively.
We balance the tradeoff between exploration and exploitation and
search the sequence landscape, aiming for more precise epitope targeting and
better developability after each iterative design cycle.
We train deep learning models to predict binding between antibodies and antigens. With ever-growing structural a=nd functional data, our models become more precise and detailed.
We train deep learning models to predict binding between antibodies and antigens. With ever-growing structural a=nd functional data, our models become more precise and detailed.
We are building a team of passionate scientists and engineers to drive scientific advances and technology innovations for bringing better therapies and improving human health.